Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Robert S. Langer,Jr,Sc.D.,PhDN/A950,0221.79%2008-08-08
Alan L. CraneDirector613,8201.16%2010-04-14
Genesh Venkataraman Kaundinya, PhDSenior V.P., Research418,1250.79%2014-12-10
Dr. Ram Sasisekharan,PhDDirector340,2740.64%2010-07-23
Craig A. WheelerPresident281,1300.53%2014-11-25
Steven B. BruggerCOO264,9180.5%2010-10-28
Richard P. SheaSVP, CFO189,0010.36%2015-01-16
Dr. John L. Zabriskie,PhDN/A149,5980.28%2004-06-25
Bruce A. LeicherSVP & General Counsel126,9980.24%2014-11-25
John Bishop,PhDSenior VP, Pharmaceutical Scie108,5050.2%2014-11-26

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Shapiro Bennett MDirector2014-12-15Sell5,80010,834$12.1970.7-11.81Link
Franken MichaelPresident, Biosimilars Busines2014-12-11Sell2,04722,953$12.2925.2-12.53Link
Shapiro Bennett MDirector2014-12-01Sell9,90310,834$12118.8-10.42Link
Shapiro Bennett MDirector2014-11-28Sell1,89710,834$1222.8-10.42Link
Bishop John ESenior VP, Pharmaceutical Scie2014-11-26Sell64108,505$11.60.7-7.33Link
WHEELER CRAIG APresident2014-11-25Sell2,210281,130$11.5925.6-7.25Link
Bishop John ESenior VP, Pharmaceutical Scie2014-11-25Sell346108,846$11.624-7.49Link
Roach James M.Senior VP, Development and Chi2014-11-25Sell391102,155$11.64.5-7.33Link
Leicher BruceSVP & General Counsel2014-11-25Sell192126,998$11.672.2-7.88Link
Kaundinya Ganesh VenkataramanSenior V.P., Research2014-11-25Sell211393,125$11.672.5-7.88Link
Shea Richard PSVP, CFO
(Click for the stocks that their CFOs have bought)
2014-11-25Sell192177,751$11.672.2-7.88Link
Bishop John ESenior VP, Pharmaceutical Scie2014-11-20Sell228108,915$11.132.5-3.41Link
Kaundinya Ganesh VenkataramanSenior V.P., Research2014-11-20Sell228393,336$11.132.5-3.41Link
Roach James M.Senior VP, Development and Chi2014-11-20Sell250102,354$11.132.8-3.41Link
Shea Richard PSVP, CFO
(Click for the stocks that their CFOs have bought)
2014-11-20Sell228177,943$11.132.5-3.41Link
Leicher BruceSVP & General Counsel2014-11-20Sell228127,190$11.132.5-3.41Link
WHEELER CRAIG APresident2014-11-20Sell1,768252,106$11.119.6-3.15Link
Bishop John ESenior VP, Pharmaceutical Scie2014-11-17Sell217109,143$10.642.31.03Link
Roach James M.Senior VP, Development and Chi2014-11-17Sell217102,604$10.642.31.03Link
Leicher BruceSVP & General Counsel2014-11-17Sell269127,418$10.642.91.03Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK